Genea Biocells US, Inc. Email Format
Research ServicesCalifornia, United States2-10 Employees
Genea Biocells US, Inc. is a research services company focused on neuromuscular diseases. It operates a proprietary platform designed to accelerate drug development for these conditions, many of which are rare orphan diseases with limited treatment options. The company has developed a skeletal muscle differentiation method that produces disease-relevant tissue for modeling and screening, enabling studies not possible with traditional approaches. The company has lead programs targeting facioscapulohumeral muscular dystrophy and spinal muscular atrophy, with discovery-stage work for Kennedy's disease, LAMA2 congenital muscular dystrophy, and congenital myotonic dystrophy. Based in San Diego, California, Genea Biocells originated from the Australian Genea group, a company with a long history in IVF clinics since 1985.